banner

Investors

At ACADIA, we remain deeply committed to providing important new therapies to patients and delivering value for our stockholders. Our Investor Center is designed to provide you with convenient access to company information.

Recent News

02/12/20
Summary ToggleACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on February 26, 2020
ACADIA to Host Conference Call and Webcast on Wednesday, February 26, 2020 , at 5:00 p.m. Eastern Time SAN DIEGO --(BUSINESS WIRE)--Feb. 12, 2020-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2019 financial results on Wednesday,
01/07/20
Summary ToggleACADIA Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020
SAN DIEGO --(BUSINESS WIRE)--Jan. 7, 2020-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at
12/18/19
Summary ToggleACADIA Pharmaceuticals Appoints Stephanie Fagan as Senior Vice President, Corporate Affairs and Chief Communications Officer
SAN DIEGO --(BUSINESS WIRE)--Dec. 18, 2019-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Stephanie Fagan has been appointed to the newly created position of Senior Vice President, Corporate Affairs and Chief Communications Officer. Ms.
2019 | 2018 | 2017 | Archive
Webcasts
Click here for webcast
Click here for webcast
Q4 2019 ACADIA Pharmaceuticals Earnings Conference Call
 02/26/20 at 5:00 PM EST

Stock Quote

Exchange
Price
Change (%)  
Volume
02/24/20 7:07 am EST
Copyright West LLC.
Minimum 15 minutes delayed.

Refresh quote

Copyright West LLC. Minimum 15 minutes delayed.